Company intelligence / Profile preview

i-ChinaPharma-Intelligence

Haikou, Hainan Province, Chinalinkedin.com ↗

Ownership: Private
Employees: ~224
Development stage: Other

Overview

China Pharma Holdings develops, manufactures, and markets a broad range of generic pharmaceuticals and some traditional Chinese medicines for high-incidence diseases in China. Their products include injectables, tablets, capsules, granules, and oral solutions targeting infectious diseases, CNS disorders, cardiovascular conditions, digestive diseases and more. The company has over 16 commercialized drugs with ongoing development in new generics.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeTraditional Chinese medicineBiologic
Industry: Biotech

Drug pipeline

1 asset

alginic sodium diester

Unknown

Beyond the preview

Go deeper on i-ChinaPharma-Intelligence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-ChinaPharma-Intelligence.

Explore the full profile